BREAKING

Berkshire Hathaway Sells $69M of DaVita Stock Amid HHS Kidney Reforms, Securities Fraud Probe

International Business Times UK — November 03, 2026 at 04:19 PM UTC

■ Source Bias Analysis 1 rating found

LEFTLEAN LEFTCENTERLEAN RIGHTRIGHT

Wikipedia GENERALLY UNRELIABLE International Business Times

Berkshire Hathaway sold $69 million in DaVita shares as HHS unveils a kidney-care plan and Pomerantz investigates potential securities fraud.

READ MORE AT SOURCE »

HOW DO YOU SEE THIS STORY?

Choose your pill. Your vote is anonymous.

0 TOTAL VOTES

SCAN TO SHARE

« Back to The Culture War